Adetunji T. Toriola, MD, PhD
Associate Professor of Surgery
- Phone: 314-286-2668
- Email: email@example.com
Medical School: MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004
MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011
Post Doctoral Education
Postdoctoral Fellowship: German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012
Dr. Toriola’s research focuses on characterizing the molecular basis and determinants of mammographic breast density that are targetable, especially in premenopausal women, and to translate study findings to breast cancer prevention, through clinical trials.
He is the PI on an NIH/NCI funded phase II clinical trial investigating the effect of RANKL inhibition on mammographic breast density and breast tissue/blood markers in premenopausal women with dense breasts (R37CA235602: https://clinicaltrials.gov/ct2/show/NCT04067726).
In addition, he performs molecular epidemiologic studies on colorectal and pancreatic cancers, evaluating the utility of biomarkers to investigate the associations of energetics, and inflammation with risk/mortality. He is an MPI on the ColoCare Study (U01 CA206110: https://clinicaltrials.gov/ct2/show/NCT02328677), a large multicenter cohort of colorectal cancer (CRC) patients for interdisciplinary studies of CRC prognosis and outcomes.
660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110